Aller au contenu principal
Profil bibliographique

Andrew Kolodziej

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

74Publications signalées
337Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Mechanical Circulatory Support DevicesTransplantation: Methods and OutcomesCardiac Structural Anomalies and RepairCardiac pacing and defibrillation studiesCardiac Arrest and Resuscitation

Les publications récentes

Accès ouvert 2026 article OpenAlex

Sotatercept in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension and Eisenmenger Syndrome

Gillian P. Leung, Elaine C. Major, Sydney C. Cason, Andrew Kolodziej et autres

BACKGROUND: Eisenmenger syndrome (ES) is a form of World Health Organization Group 1 pulmonary arterial hypertension (PAH). Initial therapy typically involves monotherapy with an endothelin-receptor antagonist or a phosphodiesterase-5 inhibitor, whereas evidence for advanced therapies remains limited. Sotatercept, a first-in-class therapy, modulates …

us (code pays fourni par la source)

2 citations JACC Case Reports
2025 article OpenAlex

Combined cellular and antibody-mediated rejection of orthotopic heart transplant following influenza A infection

Jeffrey Spindel, Nathan R. Shelman, Vasili Katsadouros, Andrew Kolodziej

Viral infections have been associated with acute allograft rejection in solid organ transplant recipients. Influenza infection upregulates host proinflammatory cytokines, suggesting the host immune response can precipitate graft rejection. Pandemic influenza, specifically, was associated with rejection in multiple renal allograft recipients. However, …

us (code pays fourni par la source)

0 citations BMJ Case Reports
Accès ouvert 2024 article OpenAlex

Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy

AARON B. HESSELSON, Gaurang Nandkishor Vaidya, Andrew Kolodziej

Cardiac contractility modulation (CCM) can be a therapeutic aid in class III chronic systolic congestive heart failure, not indicated for biventricular pacing, and with left ventricular ejection fraction (LVEF) 25% to 45%.1 Recent observational data by Fastner and colleagues2 suggest a greater …

us (code pays fourni par la source)

0 citations Heart Rhythm O2

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.